Bristol-Myers Matches Earnings Forecast

Health CareReuters

Bristol-Myers Squibb Matches EPS Estimates

Earnings HQ: FBN’s Diane Macedo breaks down BMY’s first-quarter earnings report.

Bristol-Myers Squibb Co reported lower first-quarter earnings, in line with forecasts, thanks to unexpectedly lower taxes and sharply higher sales of its treatments for melanoma, leukemia and diabetes.

Continue Reading Below

The company on Thursday said it earned $609 million, or 37 cents per share, in the quarter. That compared with $1.1 billion, or 64 cents per share in the year-earlier period.